Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid

Lancet
Ronald D GonzalesJohn Quinn

Abstract

Linezolid is a new oxazolidinone antibiotic used to treat infections caused by vancomycin-resistant enterococci (VRE). In early clinical trials, emergence of resistance occurred rarely. We report clinical details and antibiotic susceptibility from five patients treated with linezolid for VRE infections who had resistant organisms isolated during therapy. Four were transplant patients receiving protracted courses of the drug; three cases were associated with treatment failure. One of 45 linezolid-treated patients developed resistance during therapy. Susceptibility testing should be done in all cases on starting therapy.

References

Jun 22, 2000·The Medical Letter on Drugs and Therapeutics

❮ Previous
Next ❯

Citations

Apr 5, 2002·Chembiochem : a European Journal of Chemical Biology·Roderich D Süssmuth
Jul 4, 2006·Indian Journal of Pediatrics·Hossam Al-TatariBasim Asmar
Aug 19, 2007·Folia Microbiologica·D JahodaA Sosna
Dec 17, 2009·European Journal of Clinical Pharmacology·Stefanie SwobodaMarkus A Weigand
Sep 4, 2010·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·P SchnitzlerH K Geiss
Jul 31, 2013·International Journal of Clinical Pharmacy·Bhavarth S ShuklaLilian Abbo
Feb 21, 2002·Current Infectious Disease Reports·Gerald A. Evans
Aug 29, 2006·Current Infectious Disease Reports·George M Eliopoulos
Oct 9, 2013·Current Infectious Disease Reports·Gopi PatelShirish Huprikar
Nov 19, 2003·Bioorganic & Medicinal Chemistry Letters·Mikhail F GordeevDinesh V Patel
Nov 19, 2003·Bioorganic & Medicinal Chemistry Letters·Michael B GravestockAlan Wookey
May 24, 2005·Bioorganic & Medicinal Chemistry Letters·Prasad P DixitNeelima Sinha
Feb 20, 2004·Diagnostic Microbiology and Infectious Disease·Jennifer M StreitRonald N Jones
Jan 21, 2004·International Journal of Antimicrobial Agents·Tamara R Anderegg, Ronald N Jones
Jan 21, 2004·International Journal of Antimicrobial Agents·Mark W StockdaleNeil Woodford
Dec 12, 2002·Phytochemistry·Simon GibbonsAlexander I Gray
Nov 5, 2003·International Journal of Food Microbiology·Ingo KlareWolfgang Witte
Jul 12, 2003·The Journal of Hospital Infection·A P JohnsonUNKNOWN ICU Study Group
Mar 20, 2002·Burns : Journal of the International Society for Burn Injuries·J L AtkinsP Dziewulski
Sep 18, 2002·Fitoterapia·Simon GibbonsInga Johnsen
Feb 23, 2002·Diagnostic Microbiology and Infectious Disease·Ronald N JonesTamara R Anderegg
Jun 8, 2002·Diagnostic Microbiology and Infectious Disease·Charles H BallowUNKNOWN North American ZAPS Research Group
Nov 5, 2003·Diagnostic Microbiology and Infectious Disease·Kathleen A RuggeroJohn P Quinn
Jun 7, 2003·International Journal of Antimicrobial Agents·M BassettiL M Dembry
Dec 7, 2002·Bioorganic & Medicinal Chemistry·O A PhillipsN Al-Hassawi
Mar 7, 2002·Microbes and Infection·Brett D Shepard, Michael S Gilmore
Jan 5, 2002·Current Opinion in Pharmacology·I Chopra
Jan 22, 2003·Seminars in Dialysis·Jeffrey S Berns
Jun 22, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·H S Gold
May 1, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Michele TillPeter E Pertel
May 17, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Amar SafdarDonald E Saunders
May 29, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Christine L Wigen, Matthew B Goetz
Nov 1, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Manjunath P PaiJohn P Quinn
Jan 11, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Mary C BirminghamJerome J Schentag
Feb 5, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·George M Eliopoulos
May 27, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Sibtain RahimRobert A Press
Jul 29, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·S M ZimmerJ Somani
Oct 9, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Venkata G Meka, Howard S Gold
May 24, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Lluis PalenzuelaMichio Hirano
Jun 17, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Brian A PotoskiDavid L Paterson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.